ganciclovir sodium

FDA Drug Profile — ganciclovir, Ganciclovir, ganciclovir sodium

Drug Details

Generic Name
ganciclovir sodium
Brand Names
ganciclovir, Ganciclovir, ganciclovir sodium
Application Number
ANDA207645
Sponsor
Sagent Pharmaceuticals
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
GANCICLOVIR SODIUM

Indications and Usage

1 INDICATIONS AND USAGE Ganciclovir Injection is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the: treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). ( 1.1 ) prevention of CMV disease in adult transplant recipients at risk for CMV disease. ( 1.2 ) 1.1 Treatment of CMV Retinitis Ganciclovir Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS) [see Clinical Studies ( 14.1 )] . 1.2 Prevention of CMV Disease in Transplant Recipients Ganciclovir Injection is indicated for the prevention of CMV disease in adult transplant recipients at risk for CMV disease [see Clinical Studies ( 14.2 )].